Income Statement - NewAmsterdam Pharma Co N.V. (NAMS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total revenue | 22.50 | 45.56 | 14.09 | 102.69 | 0.00 | 0.00 |
| Cost of revenue | 0.06 | 0.11 | 0.04 | 0.07 | 0.01 | |
| Gross profit | 22.44 | 45.56 | 14.09 | 102.69 | -0.01 | |
| Total operating expenses | 248.13 | 221.85 | 197.06 | 106.25 | 34.98 | 6.63 |
| Operating income | -225.68 | -176.29 | -182.97 | -3.56 | -34.98 | -6.63 |
| Non-operating income (net) | 21.86 | -65.31 | 6.06 | -19.08 | -6.81 | -0.39 |
| Income before tax | -203.82 | -241.60 | -176.91 | -22.63 | -41.79 | -7.02 |
| Income tax expense | 0.00 | 0.03 | 70.83 | 0.22 | 0.34 | |
| Net income | -203.82 | -241.60 | -176.94 | -22.63 | -41.79 | -7.02 |
Show Quarterly Income Statement
Income Statement - NewAmsterdam Pharma Co N.V. (NAMS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.04 | 0.03 | 0.35 | 19.15 | 2.98 | 12.77 | 29.11 | 2.28 | 1.40 | 0.80 | 2.94 | 1.72 | 8.63 | 5.50 | 5.50 | 48.98 | 51.72 | ||||||||
| Cost of revenue | 0.50 | 0.06 | 0.06 | 0.05 | 0.05 | 0.02 | 0.01 | ||||||||||||||||||
| Gross profit | 2.54 | -0.03 | 0.35 | 19.15 | 2.98 | 12.77 | 29.11 | 2.28 | 1.40 | 0.80 | 2.94 | 1.72 | 8.63 | 5.50 | 5.50 | 48.98 | 51.72 | ||||||||
| Total operating expenses | 60.96 | 65.95 | 55.49 | 54.78 | 71.90 | 56.00 | 54.11 | 54.85 | 56.88 | 51.88 | 52.50 | 44.20 | 47.26 | 33.57 | 33.57 | 20.89 | 22.06 | 18.01 | 17.28 | 5.90 | 5.83 | 0.13 | -1.36 | -1.36 | -1.36 |
| Operating income | -58.42 | -65.98 | -55.14 | -35.64 | -68.93 | -43.23 | -25.00 | -52.58 | -55.48 | -51.07 | -49.56 | -42.48 | -39.85 | -28.07 | -28.07 | 28.09 | 29.66 | -18.01 | -17.28 | -5.90 | -5.83 | -0.13 | -1.36 | -1.36 | -1.36 |
| Non-operating income (net) | 9.98 | -8.94 | -16.86 | 18.27 | 29.40 | -48.95 | 8.36 | 13.57 | -38.29 | 1.61 | 2.43 | 4.19 | -2.17 | -9.98 | -9.98 | 0.47 | 0.50 | -2.12 | 6.21 | 0.28 | 0.28 | 0.17 | -0.08 | -0.08 | -0.08 |
| Income before tax | -48.44 | -74.92 | -72.01 | -17.36 | -39.53 | -92.18 | -16.65 | -39.01 | -93.77 | -49.47 | -47.13 | -38.29 | -42.02 | -38.04 | -38.04 | 28.56 | 30.15 | -20.13 | -11.07 | -5.62 | -5.56 | 0.04 | -1.44 | -1.44 | -1.44 |
| Income tax expense | 0.00 | -12.39 | -3.10 | 0.03 | 0.01 | -3.39 | 3.39 | 1.09 | 0.05 | 0.36 | 0.36 | 0.36 | 0.01 | 0.01 | 0.01 | 0.01 | |||||||||
| Net income | -48.44 | -74.92 | -72.01 | -17.36 | -39.53 | -92.18 | -16.65 | -39.01 | -93.77 | -49.50 | -47.13 | -38.29 | -42.02 | -38.04 | -38.04 | 28.56 | 30.15 | -20.13 | -11.07 | -5.62 | -5.56 | 0.04 | -1.44 | -1.44 | -1.44 |